Action

EGFR

Alt Name

Approval Jurisdiction

2002 Japan, 2003 FDA

Approved for clinical use

NSCLC

Brutto

C₂₂H₂₄ClFN₄O₃

CAS

184475-35-2

Commercial Vendor

Astra Zeneca

Compound Image

Gefitinib.png

Compound name

Gefitinib

InChI

InChI=1S/C22H24ClFN4O3/c1-29-20-13-19-16(12-21(20)31-8-2-5-28-6-9-30-10-7-28)22(26-14-25-19)27-15-3-4-18(24)17(23)11-15/h3-4,11-14H,2,5-10H2,1H3,(H,25,26,27)

InChI Key

XGALLCVXEZPNRQ-UHFFFAOYSA-N

PubChem CID

123631

Reference

Reference 2

SMILES

COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)OCCCN4CCOCC4

Approved Drug List

1